Drug-induced immune hemolytic anemia
Information, Symptoms, Treatments and Resources
Drug-induced immune hemolytic anemia is a blood disorder that occurs when a medicine tells the body's defensive (immune) system to attack red blood cells. It causes red blood cells to break down earlier than normal.
See also: Hemolytic anemia
Immune hemolytic anemia secondary to drugs; Anemia - immune hemolytic - secondary to drugs
Drug-induced immune hemolytic anemia occurs when a drug causes your body's immune system to react against red blood cells. In some cases, a drug can cause the immune system to mistakenly think the red blood cells are dangerous, foreign substances. Antibodies form against the red blood cells. The antibodies attach to red blood cells and cause them to break down too early.
Drugs that can cause this type of hemolytic anemia include:
- Cephalosporins
- Levodopa
- Methyldopa
- Penicillin and its derivatives
- Quinidine
- Some anti-inflammatory drugs
There are many other rarer causes of drug-induced hemolytic anemia. Drug-induced hemolytic anemia is associated with G6PD deficiency. But in this case, the breakdown of red blood cells is due to a certain type of stress in the cell, not the body's immune system.
Drug-induced hemolytic anemia is rare in children.
- Dark urine
- Fatigue
- Pale skin color
- Rapid heart rate
- Shortness of breath
- Yellow skin color (jaundice)
A physical examination may show an enlarged spleen. A number of blood and urine tests may be done to help diagnose this condition.
- Direct Coombs' test is positive.
- Indirect Coombs' test is positive if the offending drug is added to the test.
- Indirect bilirubin levels are high.
- Serum haptoglobin may be low.
- Hemoglobin may be found in the urine.
- Hemosiderin may be found in the urine.
- Urine and fecal urobilinogen are increased.
- Absolute reticulocyte count is high.
- Red blood cell count shows low hemoglobin.
Stopping the drug that is causing the problem may relieve or control the symptoms.
Some persons may be given a medicine called prednisone. Special blood transfusions may be needed to treat severe symptoms.
Death caused by severe anemia rarely occurs. Transfusion can cause a transfusion reaction.
See your health care provider if you have symptoms of this condition.
Vandendries ER. Drug-associated disease: hematologic dysfunction. Crit Care Clin. April 2006; 22(2): 347-55, viii.
Dhaliwal G. Hemolytic anemia. Am Fam Physician. June 2004; 69(11): 2599-606.
Kasper D, Braunwald E, Fauci A, et al. Harrison's Principals of Internal Medicine. 16th edition [online version]. New York, NY: McGraw Hill; 2005.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. � 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
